Trump's Executive Order on Medicare
Allie Clark | 2 min read | October 25, 2019
In an executive order signed on October 3rd, 2019 at a Florida retirement home, President Trump offered his rebuttal to the “Medicare for All” proposals of his presidential opponents. Within that order is a slew of requests for proposals from Health and Human Services in periods of six months and one year. Among those requests, which are aimed at improving and maximizing both corporate competition and patient choice, are four that mention telehealth and other virtual care technologies.
In the midst of asking for strategies to reduce the unnecessary burdens that Medicare infamously puts of physicians as far as reporting, requirements, and documentation, he asks for price equality between Medicare Advantage plans and fee-for-service Medicare, data transparency on quality and cost measurements for consumers, and barrier reduction for all aspects of Medicare coverage, but especially telehealth and care innovations. He goes so far as to order a full evaluation of the dual reviews done by both the FCC and CMS of new technology as well as a reduction of the time spent making those determinations. President Trump pushes for market-value reimbursement for Medicare providers and coverage of services and products by Medicare Advantage plans that FFS Medicare won’t cover, as well as a full review of the process CMS uses to decide what to cover.
It is clear that President Trump and his administration are dedicated to the belief that what will save our nation’s broken healthcare system is increasing healthy competition and maximizing informed choices for consumers’ healthcare options, especially those with Federally funded insurance. This order, if nothing else, very clearly communicates their commitment to that process in one of the most sweeping and revolutionary orders of the Trump presidency. Moreover, it is refreshing to hear the benefits of telehealth technology in improving access to the quality of care touted at the highest level of influence and authority. As we wait and watch for those reports and proposals to come in, we can only hope that they will be acted upon and used to promote growth and improvement in the Medicare landscape for everyone, providers and patients alike.
To read the article from mhealthintelligence, click here.
To read the article from MedCityNews, click here.
Call 877-83-VISIT today to speak to one of our specialists and find out how SimpleVisit can help you stay ahead of the game as these sweeping Medicare reform talks are taking place.
Don’t miss the latest telehealth news! Follow us on Facebook, Twitter and LinkedIn – and fill out the form below to subscribe to our newsletter.
Allie Clark
Allie is the Industry Analyst and Content Manager for SimpleVisit. Her educational background is diverse with Administrative Medical Assisting and Psychology as a focus with a dash of Business Communication and Theater. Events in her life have led to a passion for improving access to healthcare and a particular talent for research, which she is quickly turning into a career. Allie is able to use her combined experience to write and develop resources for SimpleVisit, and is fulfilled by the opportunity to contribute to innovation and progress in the healthcare industry as a whole.
Telehealth and Telemedicine: What’s the Difference?
The following article is originally featured on mhealthintelligence.com: Today’s healthcare ecosystem is filled with references to and examples of telemedicine and telehealth – in some cases, the two terms are used interchangeably. Whether they mean the same thing is...
Simple Summary: Telemedicine News
January 30, 2018 New Integration with Athenahealth SimpleVisit has partnered with Athenahealth to improve access to care as part of their More Disruption Please program. This means that Athena users can now add our telemedicine service through the...
Simple Summary: Recent Telemedicine Related News
Recent Telemedicine news that caught our eyes. The information you may have missed but need to know. The FDA Has Approved The First Digital Pill: The Food and Drug Administration has approved the first digital pill for the U.S. called Abilify MyCite....